- Home
- ATOS vs OWLT Comparison
ATOS vs OWLT Comparison
Compare ATOS & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- OWLT
- Stock Information
- Founded
- ATOS 2009
- OWLT 2013
- Country
- ATOS United States
- OWLT United States
- Employees
- ATOS N/A
- OWLT N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ATOS Health Care
- OWLT Health Care
- Exchange
- ATOS Nasdaq
- OWLT Nasdaq
- Market Cap
- ATOS 107.2M
- OWLT 98.3M
- IPO Year
- ATOS 2012
- OWLT N/A
- Fundamental
- Price
- ATOS $0.78
- OWLT $7.56
- Analyst Decision
- ATOS Strong Buy
- OWLT
- Analyst Count
- ATOS 3
- OWLT 0
- Target Price
- ATOS $6.17
- OWLT N/A
- AVG Volume (30 Days)
- ATOS 1.3M
- OWLT 98.6K
- Earning Date
- ATOS 08-12-2025
- OWLT 08-07-2025
- Dividend Yield
- ATOS N/A
- OWLT N/A
- EPS Growth
- ATOS N/A
- OWLT N/A
- EPS
- ATOS N/A
- OWLT N/A
- Revenue
- ATOS N/A
- OWLT $89,774,000.00
- Revenue This Year
- ATOS N/A
- OWLT $21.93
- Revenue Next Year
- ATOS N/A
- OWLT $22.54
- P/E Ratio
- ATOS N/A
- OWLT N/A
- Revenue Growth
- ATOS N/A
- OWLT 36.78
- 52 Week Low
- ATOS $0.55
- OWLT $2.75
- 52 Week High
- ATOS $1.66
- OWLT $10.30
- Technical
- Relative Strength Index (RSI)
- ATOS 45.59
- OWLT 47.86
- Support Level
- ATOS $0.81
- OWLT $7.08
- Resistance Level
- ATOS $0.80
- OWLT $8.40
- Average True Range (ATR)
- ATOS 0.03
- OWLT 0.95
- MACD
- ATOS -0.00
- OWLT -0.08
- Stochastic Oscillator
- ATOS 39.58
- OWLT 33.09
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.